Drug Profile
MRZ 8676
Alternative Names: MRZ-8676Latest Information Update: 11 May 2016
Price :
$50
*
At a glance
- Originator Merz Pharmaceuticals
- Class
- Mechanism of Action Metabotropic glutamate receptor 5 modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Drug-induced dyskinesia
Most Recent Events
- 11 May 2016 Chemical structure information added